 WATERTOWN, Mass.--BUSINESS WIRE--SQZ Biotechnologies NYSE: SQZ, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that management will be presenting at the Chardan 5th Annual Genetic Medicines Conference on October 4. Armon Sharei, Ph.D., Chief Executive Officer, will present a corporate overview and the company will be hosting one-on-one meetings. PRESENTATION DETAILS Monday, October 4 Chardan 5th Annual Genetic Medicines Conference F 